GRANULES - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.4
| Stock Code | GRANULES | Market Cap | 19,557 Cr. | Current Price | 790 ₹ | High / Low | 804 ₹ |
| Stock P/E | 47.7 | Book Value | 178 ₹ | Dividend Yield | 0.22 % | ROCE | 12.8 % |
| ROE | 10.5 % | Face Value | 1.00 ₹ | DMA 50 | 728 ₹ | DMA 200 | 628 ₹ |
| Chg in FII Hold | 1.76 % | Chg in DII Hold | -0.46 % | PAT Qtr | 99.0 Cr. | PAT Prev Qtr | 112 Cr. |
| RSI | 62.3 | MACD | 10.2 | Volume | 18,50,835 | Avg Vol 1Wk | 15,41,750 |
| Low price | 433 ₹ | High price | 804 ₹ | PEG Ratio | -7.45 | Debt to equity | 0.19 |
| 52w Index | 96.0 % | Qtr Profit Var | 36.1 % | EPS | 16.2 ₹ | Industry PE | 32.5 |
📊 Granules India (GRANULES) shows moderate fundamentals with [ROCE](ca://s?q=Explain_ROCE) at 12.8% and [ROE](ca://s?q=Explain_ROE) at 10.5%, reflecting average efficiency. The company has manageable leverage (0.19 debt-to-equity), which adds stability. However, the [P/E valuation](ca://s?q=Explain_P/E_ratio) of 47.7 is higher than the industry average (32.5), suggesting premium pricing. The [PEG ratio](ca://s?q=Explain_PEG_ratio) of -7.45 indicates negative growth prospects, raising caution. Dividend yield (0.22%) is negligible, offering little income support. Quarterly PAT declined (99 Cr vs 112 Cr), though profit variation (36.1%) shows volatility.
💡 The ideal entry price zone would be near 700–730 ₹, close to DMA 50 (728 ₹) and below current levels, offering a margin of safety. RSI (62.3) suggests the stock is nearing overbought territory, while MACD (10.2) shows bullish momentum, making dips favorable for accumulation.
📈 For existing holders, a medium-term horizon of 2–3 years is recommended, given volatility in earnings and expensive valuations. Exit strategy: consider partial profit booking near 790–800 ₹ (recent highs), while retaining core holdings only if efficiency improves.
✅ Positive
- 📌 Manageable debt-to-equity ratio (0.19).
- 📌 Rising FII holdings (+1.76%).
- 📌 Strong profit variation (36.1%).
- 📌 Stock trading near 52-week high (804 ₹).
⚠️ Limitation
- 📌 High P/E ratio (47.7) compared to industry average (32.5).
- 📌 Negative PEG ratio (-7.45) indicates poor growth valuation.
- 📌 Very low dividend yield (0.22%).
- 📌 Decline in quarterly PAT (99 Cr vs 112 Cr).
📉 Company Negative News
- 📌 No major negative news reported, but earnings volatility and valuation risks persist.
📈 Company Positive News
- 📌 Rising FII interest (+1.76%) shows foreign investor confidence.
- 📌 Strong trading momentum with bullish MACD signals.
🏭 Industry
- 📌 Industry P/E at 32.5, lower than Granules’ 47.7, suggesting overvaluation.
- 📌 Pharma sector benefits from global demand but faces regulatory and pricing pressures.
🔎 Conclusion
Granules India is a moderately strong candidate for medium-term investment, supported by manageable debt and rising FII interest. However, high valuations, negative PEG ratio, and weak dividend yield limit long-term attractiveness. The ideal entry zone is 700–730 ₹. Current holders should maintain positions for 2–3 years, with partial profit booking near 790–800 ₹ while retaining core shares only if efficiency improves.